Search | Directory | Events | Press Releases | Company News | Maps | LifeScience.TV | Reports | The Mall | BioCentral | Sudoku

	Clinical Trials News		Pharma Biotech News
	Gentium Provides an Update on the Phase 3 Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease Wed, 19 Nov 2008 VILLA GUARDIA, Italy--(BUSINESS WIRE)--Gentium S.p.A. (NASDAQ: GENT) announced today interim results from an independent Data Safety Monitoring Board (DSMB) review of the Company's Phase 3 treatment trial of BioDelivery Sciences Remains on Schedule for December ONSOLIS Resubmission Following Meeting with FDA Wed, 19 Nov 2008 RALEIGH, N.C.--(BUSINESS WIRE)--BioDelivery Sciences International, Inc., (Nasdaq: BDSI) announced that the company continues to anticipate a resubmission containing the Risk Evaluation and Mitigation Strategy (REMS) TaconicArtemis Announces Publication in PNAS: Inducible Gene Silencing in Transgenic Rats via RNAi Wed, 19 Nov 2008 COLOGNE, Germany--(BUSINESS WIRE)--TaconicArtemis GmbH, a subsidiary of Taconic today announced the publication of a scientific breakthrough achieved in a collaboration with the Universities Goettingen and Wuerzburg Power3 Medical Files Two CIP Patent Applications for BC-SeraPro Breast Cancer Blood Test and Biomarkers Wed, 19 Nov 2008 HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB: PWRM, www.power3medical.com) said today that two CIP patent applications have been filed for BC-SeraPro™ Breast Cancer blood test and biomarkers by Quintiles, SAS Announce Development of First-Ever Clinical Trials Statistical Programming Certification Wed, 19 Nov 2008 RESEARCH TRIANGLE PARK & CARY, N.C.--(BUSINESS WIRE)--Quintiles, the world’s No. 1 pharmaceutical services company, and SAS are developing a unique program to produce certified specialists in the use of SAS Nymox Announces NEXUS-1 and NEXUS-2 Phase 3 Trials for NX-1207 Investigational Drug for BPH Wed, 19 Nov 2008 HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce the NEXUS-1 and NEXUS-2 Phase 3 clinical trials for NX-1207, the Company's new drug for benign prostatic Research and Markets: This Essential Report on the Malaysian Pharmaceuticals and Healthcare Industry is Now Available Wed, 19 Nov 2008 DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d39f3c/malaysia_pharmaceu) has announced the addition of the "Malaysia Pharmaceuticals and Healthcare Report Q4 2008" KAI Reports Positive Preclinical Results for KAI-1678, First-in-Class Compound to Treat Pain Wed, 19 Nov 2008 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in Applied NeuroSolutions’ Q3 2008 Alzheimer’s Disease Serum Diagnostic Development Program Update Wed, 19 Nov 2008 VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.AppliedNeuroSolutions.com), a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings Wed, 19 Nov 2008 NEW YORK--(BUSINESS WIRE)--Pervasis Therapeutics, Inc., a biotechnology company pioneering biologically active therapies and devices to treat serious illnesses, will present new efficacy data from Phase 1 and 2		Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee SANGAMO BIOSCIENCES, INC.- PRNewswire - SyntheMed Announces FDA Clearance of SinusShield(TM) SyntheMed, Inc.- PRNewswire - Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing Serica Technologies, Inc.- PRNewswire - Technical Note: E-PAGE(TM) 48- and 96-Well Gels on the Odyssey(R) Infrared Imaging System LI-COR Biosciences- PRNewswire - GEN Reports on the Trend Toward Predictive Toxicogenomics Mary Ann Liebert, Inc.~~GEN- PRNewswire - Media Advisory - Atlantica BioEnergy Task Force Leaders' Roundtable Atlantica BioEnergy Task Force- PRNewswire - PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel PharmAthene, Inc.- PRNewswire - Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile Neptune Technologies & Bioressources Inc.- PRNewswire - Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit Synvista Therapeutics, Inc.- PRNewswire - Helix BioPharma Presents Preclinical L-DOS47 Data at The Second Conference of Lung Cancer in Warsaw, Poland The Second Conference of Lung Cancer- PRNewswire - American HealthChoice Announces the First Sales of the OmniBody Scan American HealthChoice, Inc.- PRNewswire - ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China ChinaBio- PRNewswire - Tengion Announces Second Closing of Series C Financing Tengion Inc.- PRNewswire - MiddleBrook Pharmaceuticals Hires Key Commercial Team Members MiddleBrook Pharmaceuticals, Inc.- PRNewswire - Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing Three Arch Partners- PRNewswire - Isogen Launches Major New Facility to Address Global Biopharma Demand Isogen- PRNewswire - GeneNews appoints Canadian Colorectal Cancer Advisory Board GeneNews Limited- PRNewswire - Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia ROCHE- PRNewswire -

For Companies in Labhoo

B2B

Submit a Site

Advertising on Labhoo

About Labhoo

Site Stats

Links

40,000 visitors per month increasing at 10% per month other Labhoo group sites include
sign up for weekly newsletter by email [example]